Quality of life assessments in major depressive disorder: a review of the literaturePAPAKOSTAS, George I; PETERSEN, Timothy; MAHAL, Yasmin et al.General hospital psychiatry. 2004, Vol 26, Num 1, pp 13-17, issn 0163-8343, 5 p.Article

Psychosocial functioning in patients with treatment resistant depressionPETERSEN, Timothy; PAPAKOSTAS, George I; MAHAL, Yasmin et al.European psychiatry. 2004, Vol 19, Num 4, pp 196-201, issn 0924-9338, 6 p.Article

Somatic symptoms in outpatients with major depressive disorder treated with fluoxetineDENNINGER, John W; PAPAKOSTAS, George I; MAHAL, Yasmin et al.Psychosomatics (Washington, DC). 2006, Vol 47, Num 4, pp 348-352, issn 0033-3182, 5 p.Article

Somatic symptoms in treatment-resistant depressionPAPAKOSTAS, George I; PETERSEN, Timothy; DENNINGER, John et al.Psychiatry research. 2003, Vol 118, Num 1, pp 39-45, issn 0165-1781, 7 p.Article

S-Adenosyl-L-methionine (SAMe) as an adjunct for resistant major depressive disorder: An open trial following partial or nonresponse to selective serotonin reuptake inhibitors or venlafaxineALPERT, Jonathan E; PAPAKOSTAS, George; MISCHOULON, David et al.Journal of clinical psychopharmacology. 2004, Vol 24, Num 6, pp 661-664, issn 0271-0749, 4 p.Article

Switching to bupropion in fluoxetine-resistant major depressive disorderFAVA, Maurizio; PAPAKOSTAS, George I; PETERSEN, Timothy et al.Annals of clinical psychiatry. 2003, Vol 15, Num 1, pp 17-22, issn 1040-1237, 6 p.Article